Related Experiment Video
Updated: Sep 29, 2025

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
Published on: October 20, 2023
Benzodiazepines utilization in Brazilian older adults: a population-based study
Marina de Borba Oliveira Freire1, Bruna Gonçalves Cordeiro Da Silva2, Andréa Dâmaso Bertoldi2
1Universidade Federal de Pelotas . Faculdade de Medicina . Programa de Pós-Graduação em Epidemiologia . Pelotas , RS , Brasil.
Benzodiazepine (BZD) use is high among Brazilian older adults, especially women and those with depression. This study highlights significant regional and sex disparities in BZD utilization.
Area of Science:
- Gerontology
- Psychopharmacology
- Public Health
Background:
- Benzodiazepines (BZD) are frequently prescribed for older adults, but their use in this population requires careful consideration due to potential risks.
- The Pesquisa Nacional de Acesso, Utilização e Promoção do Uso Racional de Medicamentos (PNAUM) provides valuable data on medication use in Brazil.
Purpose of the Study:
- To evaluate the prevalence and patterns of benzodiazepine (BZD) utilization among Brazilian older adults.
- To identify factors associated with BZD use in this demographic.
Main Methods:
- Cross-sectional study using data from the PNAUM survey (2013-2014) of 9,019 Brazilian individuals aged 60 years and older.
- Hierarchical Poisson regression analysis to determine prevalence ratios (PR) for BZD utilization.
- Data collected via semistructured household interviews.
Main Results:
- The prevalence of BZD utilization was 9.3% in older adults.
- Associated factors included female sex (PR=1.88), depression (PR=5.31), multimorbidity (PR=1.44), recent healthcare utilization (PR=1.42), polypharmacy (PR=1.26), and poor self-rated health (PR=4.16).
- Lower utilization was observed in the North region (PR=0.18) and among those with abusive alcohol consumption (PR=0.42).
Conclusions:
- Despite contraindications, benzodiazepine utilization remains high in Brazilian older adults.
- Depression, female sex, and multimorbidity are significant predictors of BZD use.
- Substantial regional and sex-based disparities in BZD utilization warrant further investigation and targeted interventions.
Related Concept Videos
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Anxiolytic Drugs: Benzodiazepines and Buspirone
CNS Depressants: Barbiturates and Benzodiazepines
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sedatives and Hypnotics Drugs: Barbiturates
Anxiolytic Drugs: Overview
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...

